Biodesix, Inc.
Predictive test for aggressiveness or indolence of prostate cancer from mass spectrometry of blood-based sample

Abstract:

A programmed computer functioning as a classifier operates on mass spectral data obtained from a blood-based patient sample to predict indolence or aggressiveness of prostate cancer. Methods of generating the classifier and conducting a test on a blood-based sample from a prostate cancer patient using the classifier are described.